Comparing Advanced Hemostasis and Ultrasound-Guided Puncture to Conventional Approaches in Distal Radial Access
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Transradial potassium ferrate hemostatic patch, Distal radial potassium ferrate hemostatic patch, Ultrasound-guidance, Conventional guidance.
- Кому может быть актуально
- Состояния в реестре: Coronary Catheterization. Базовые параметры: от 18 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Бельгия, Италия
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Comparing Advanced Hemostasis and Ultrasound-Guided Puncture to Conventional Approaches in Distal Radial Access: A Dual Randomized Pragmatic Trial
Обзор
Meta-analysis results show that distal radial access (DRA) is associated with a significant reduction in the risk of radial artery occlusion compared to conventional transradial access (TRA). This is of paramount importance in an evolving interventional context where an increasing number of radial access procedures are being performed to address a growing number of independent health conditions. DRA is also associated with a lower rate of vascular access-related adverse events, establishing it as the safest vascular access ever. However, available data show that the success rate of DRA is lower than that of conventional TRA. Also, while the duration of hemostasis has been shown to be shorter, it has most likely not yet reached its full potential for shortening. Thus, the two extreme phases of DRA require important further evaluation. The CompAring uLtrasound-guided Puncture and advanced HemostAsis to cOnventional approaches in distal radial access: a dual randoMizEd praGmatic triAl (ALPHA\&OMEGA) trial will address this lack of knowledge by exploring whether a significantly shorter hemostasis duration can be achieved with DRA when using hemostasis enhancement and exploring whether ultrasound-guided puncture can increase the success rate of DRA.
Вмешательства
- Устройство Transradial potassium ferrate hemostatic patch
Use of a potassium ferrate hemostatic patch to enhance transradial access hemostasis - Устройство Distal radial potassium ferrate hemostatic patch
Use of a potassium ferrate hemostatic patch to enhance distal radial access hemostasis - Процедура Ultrasound-guidance
Ultrasound guidance for distal radial access - Процедура Conventional guidance
Conventional guidance for distal radial access
Первичные конечные точки
- Hemostasis duration. [Срок оценки: From end of procedure to end of hemostasis (25 minutes for distal radial access and 60 minutes for conventional transradial access)]
- Access success [Срок оценки: Starts when the anesthesia needle contacts the skin and stops when the introducer sheath has been properly placed (on average 1 minute)]
Критерии участия
Критерии включения
- Age ≥18 years.
- Patients presenting with CCS or ACS, including unstable angina or NSTEMI.
- Patients planned for coronary angiography or PCI.
- Patients able to provide written informed consent.
- Patient is willing to comply with all study protocol required evaluations.
- Palpable radial pulse both at conventional and distal puncture site.
- Reverse modified Barbeau test confirming radial artery patency in patients with a history of previous radial artery catheterization.
Критерии исключения
- Acute ST-segment elevation myocardial infarction.
- Cardiogenic shock.
- Chronic hemodialysis.
- Contraindications to radial access, such as occlusive upper arm peripheral artery disease, or known anatomic variants prohibiting TRA on both sides.
- Medical conditions that may cause non-compliance with the study protocol and/or may confound the data interpretation.
- Patients unable to provide written informed consent.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Параллельные группы
- Маскирование
- Открытое
- Основная цель
- Лечение
Центры проведения
Бельгия · 3 центра
- Groupe Vivalia, Clinique Saint-Joseph — Arlon
- CHU Charleroi-Chimay, Marie Curie Hospital — Charleroi
- CHU Helora, Jolimont Hospital — La Louvière
Италия · 3 центра
- Sant'Eugenio Hospital — Roma
- Sandro Pertini Hospital — Roma
- Mater Salutis Hospital — Legnago
Идентификаторы
NCT: NCT06835829 · 2023-00123